Click here to sign in with or

Fluorinated structures make up more than 20 percent of modern drugs, but benign and fast fluorination schemes are scarce. In a study published in the European Journal of Organic Chemistry, scientists have now combined dynamic kinetic resolution and nucleophilic fluorination for the asymmetric synthesis of florfenicol, a veterinary antibiotic. After enzymatic resolution of the racemate, two different fluorination strategies both proved effective and fast. One is especially interesting for industrial production.

Fluorine substituents have many welcomed effects in drugs. Often, fluorinated compounds are more lipophilic, penetrate more easily in the cells, and enzymes may find it harder to degrade them. For example, the fluorinated antibiotic florfenicol is more active than thiamphenicol, to which it is related by a terminal fluorine instead of a hydroxy group. Florfenicol and thiamphenicol, which are both variants of chloramphenicol, are used against conjunctivitis and respiratory diseases in cattle.

Despite the relevance of fluorination, many industrial fluorination strategies still involve aggressive and harmful reagents. In the case of florfenicol, not only is the fluorinating agent expensive and corrosive, but the preparation of the two stereocenters also produces a high amount of waste. These issues prompted Fuli Zhang from China State Institute of Pharmaceutical Industry, Shanghai, China, and his colleagues, to look for more environmentally benign processes. To synthesize florfenicol, they had to construct two adjacent stereocenters of the cis-1,2-amino alcohol and introduce a terminal fluorine atom.

The scientists chose to install the fluorine as a last, separate step because the two asymmetric carbon atoms can be conveniently prepared by dynamic kinetic resolution. Kinetic resolution means that two enantiomers can be separated according to their different reactivity. The process is called "dynamic" when the two enantiomers can racemize, that is, interconvert. Then, the faster reacting enantiomer can be isolated with maximal yield.

Zhang and his colleagues designed a dynamic reductive kinetic resolution using ketoreductase enzymes as biocatalysts and glucose as the hydride source. Having established the two stereocenters by this bioenzymatic route, they explored possible fluorination reactions. Two routes of nucleophilic fluorination proved especially convincing, and both routes use amine hydrofluoride as the fluorinating reagent, which is mild and selective and can be handled in glass equipment.

For industrial manufacture, the authors also have a favorite. The route involving a cyclic sulfate intermediate outcompeted the other one containing an intermediate aziridine, a three-membered nitrogen-containing ring. The chemo-enzymatic sulfate route produced florfenicol in only five steps and showed high yield and flexibility as well as acceptable environmental and health safety. The next step will be the further exploration of the reductase enzymes in other dynamic bioreduction syntheses, the authors remark. Explore further Silver salt used to break C–C bonds in unstrained cyclic amines More information: Jie Zou et al. Asymmetric Synthesis of Florfenicol by Dynamic Reductive Kinetic Resolution with Ketoreductases, European Journal of Organic Chemistry (2018). DOI: 10.1002/ejoc.201800658 Journal information: European Journal of Organic Chemistry

Use this form if you have come across a typo, inaccuracy or would like to send an edit request for the content on this page. For general inquiries, please use our contact form. For general feedback, use the public comments section below (please adhere to guidelines).

Please select the most appropriate category to facilitate processing of your request

Thank you for taking time to provide your feedback to the editors.

Your feedback is important to us. However, we do not guarantee individual replies due to the high volume of messages.

Your email address is used only to let the recipient know who sent the email. Neither your address nor the recipient's address will be used for any other purpose. The information you enter will appear in your e-mail message and is not retained by Phys.org in any form.

Get weekly and/or daily updates delivered to your inbox. You can unsubscribe at any time and we'll never share your details to third parties.

Medical research advances and health news

The latest engineering, electronics and technology advances

The most comprehensive sci-tech news coverage on the web

This site uses cookies to assist with navigation, analyse your use of our services, collect data for ads personalisation and provide content from third parties. By using our site, you acknowledge that you have read and understand our Privacy Policy and Terms of Use.